T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Monster Beverage
MNST
$91.4B
| $207M | 0.02% |
5,397,702
-71,240
| -1% | -$2.55M |
|
452
MSCI
MSCI
$41.8B
| $207M | 0.02% |
360,030
+136,918
| +61% | +$76.8M |
|
453
Motorola Solutions
MSI
$77B
| $206M | 0.02% |
536,469
-296,655
| -36% | -$119M |
|
454
Textron
TXT
$15.1B
| $205M | 0.02% |
2,354,718
+49,287
| +2% | +$4.12M |
|
455
Aramark
ARMK
$16.1B
| $205M | 0.02% |
5,562,756
+393,193
| +8% | +$15M |
|
456
Verisk Analytics
VRSK
$24.2B
| $204M | 0.02% |
912,577
+66,323
| +8% | +$15M |
|
457
Aon
AON
$75.7B
| $204M | 0.02% |
578,391
-35,748
| -6% | -$12.5M |
|
458
KT
KT
$9.03B
| $204M | 0.02% |
10,756,040
-31,513
| -0.3% | -$588K |
|
459
Cloudflare
NET
$118B
| $204M | 0.02% |
1,034,680
-320,826
| -24% | -$67.9M |
|
460
Celestica
CLS
$43.8B
| $203M | 0.02% |
687,349
+305,265
| +80% | +$92M |
|
461
First Advantage
FA
$3.81B
| $203M | 0.02% |
13,954,320
+572,580
| +4% | +$8.07M |
|
462
Ivanhoe Electric
IE
$1.66B
| $202M | 0.02% |
12,671,551
+6,761,857
| +114% | +$96.8M |
|
463
Oneok
OKE
$58.4B
| $202M | 0.02% |
2,754,113
-492,348
| -15% | -$34.9M |
|
464
Acadia Realty Trust
AKR
$2.86B
| $202M | 0.02% |
9,832,078
-444,125
| -4% | -$8.85M |
|
465
ICICI Bank
IBN
$106B
| $202M | 0.02% |
6,774,963
+22,487
| +0.3% | +$690K |
|
466
MakeMyTrip
MMYT
$5.71B
| $201M | 0.02% |
2,448,388
+371,066
| +18% | +$30.4M |
|
467
Unilever
UL
$135B
| $201M | 0.02% |
3,067,651
+1,178,438
| +62% | +$79.2M |
|
468
SiTime
SITM
$20.7B
| $199M | 0.02% |
562,892
+213,242
| +61% | +$66.7M |
|
|
FISV
469
Fiserv Inc
FISV
$29.5B
| $197M | 0.02% |
2,939,013
-372,855
| -11% | -$31.2M |
|
470
Ameriprise Financial
AMP
$50.4B
| $196M | 0.02% |
399,528
+10,451
| +3% | +$4.96M |
|
471
Boot Barn
BOOT
$4.92B
| $195M | 0.02% |
1,103,441
+502,275
| +84% | +$93.7M |
|
472
SLM Corp
SLM
$5.22B
| $194M | 0.02% |
7,176,284
+4,236,127
| +144% | +$116M |
|
473
Vista Energy
VIST
$7.33B
| $194M | 0.02% |
3,989,783
+402,585
| +11% | +$18.2M |
|
474
Astera Labs
ALAB
$56B
| $194M | 0.02% |
1,164,414
+720,844
| +163% | +$121M |
|
475
Emerson Electric
EMR
$91.6B
| $193M | 0.02% |
1,453,860
+134,787
| +10% | +$17.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.